Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.564% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CN(c1ccccc1C(=O)Nc1cccnc1)S(C)(=O)=O
(b) CCOC(=O)c1cc(C(C)(C)C)oc1CNC(=O)c1c(C)oc2c1CCCC2
(c) OC(COC(c1ccccc1)c1ccccc1)CN1CCCCC1
Answer: a. CN(c1ccccc1C(=O)Nc1cccnc1)S(C)(=O)=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(c1ccccc1C(=O)Nc1cccnc1)S(C)(=O)=O
CN(c1ccccc1C(=O)Nc1cccnc1)S(C)(=O)=O
2-[methyl(methylsulfonyl)amino]-N-pyridin-3-ylbenzamide